The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Morgan, Gareth, Prof
    Immunologist born in July 1954
    Individual (138 offsprings)
    Officer
    2013-10-16 ~ now
    OF - director → CIF 0
    Mr Gareth Morgan
    Born in July 1954
    Individual (138 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

MORGAN IMMUNOLOGY RESEARCH LIMITED

Standard Industrial Classification
86210 - General Medical Practice Activities
Brief company account
Property, Plant & Equipment
2,674 GBP2023-10-31
4,041 GBP2022-10-31
Debtors
94,141 GBP2023-10-31
89,216 GBP2022-10-31
Cash at bank and in hand
8,266 GBP2023-10-31
96,699 GBP2022-10-31
Current Assets
102,407 GBP2023-10-31
185,915 GBP2022-10-31
Creditors
Current
80,891 GBP2023-10-31
58,882 GBP2022-10-31
Net Current Assets/Liabilities
21,516 GBP2023-10-31
127,033 GBP2022-10-31
Total Assets Less Current Liabilities
24,190 GBP2023-10-31
131,074 GBP2022-10-31
Net Assets/Liabilities
23,521 GBP2023-10-31
130,306 GBP2022-10-31
Equity
Called up share capital
1 GBP2023-10-31
1 GBP2022-10-31
Retained earnings (accumulated losses)
23,520 GBP2023-10-31
130,305 GBP2022-10-31
Equity
23,521 GBP2023-10-31
130,306 GBP2022-10-31
Average Number of Employees
42022-11-01 ~ 2023-10-31
42021-11-01 ~ 2022-10-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
14,222 GBP2023-10-31
13,294 GBP2022-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
11,548 GBP2023-10-31
9,253 GBP2022-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
2,295 GBP2022-11-01 ~ 2023-10-31
Property, Plant & Equipment
Plant and equipment
2,674 GBP2023-10-31
4,041 GBP2022-10-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
64,668 GBP2023-10-31
82,355 GBP2022-10-31
Other Debtors
Current, Amounts falling due within one year
29,473 GBP2023-10-31
6,861 GBP2022-10-31
Debtors
Current, Amounts falling due within one year
94,141 GBP2023-10-31
89,216 GBP2022-10-31
Trade Creditors/Trade Payables
Current
110 GBP2023-10-31
Other Taxation & Social Security Payable
Current
57,504 GBP2023-10-31
52,056 GBP2022-10-31
Other Creditors
Current
23,277 GBP2023-10-31
6,826 GBP2022-10-31

  • MORGAN IMMUNOLOGY RESEARCH LIMITED
    Info
    Registered number 08735181
    Inglewood, Bovingdon Green, Marlow, Buckinghamshire SL7 2JH
    Private Limited Company incorporated on 2013-10-16 (11 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-16
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.